CD200-CD200R signaling suppresses anti-tumor responses independently of CD200 expression on the tumor.

T.P. Rygiel; G. Karnam; G. Goverse; A.P. van der Marel; M.J. Greuter; R.A. van Schaarenburg; W.F. Visser; A.B. Brenkman; R. Molenaar; R.M. Hoek; R.E. Mebius; L. Meyaard

doi:10.1038/onc.2011.477

CD200-CD200R signaling suppresses anti-tumor responses independently of CD200 expression on the tumor.

T.P. Rygiel
, G. Karnam
, G. Goverse
, A.P. van der Marel
, M.J. Greuter
, R.A. van Schaarenburg
, W.F. Visser
, A.B. Brenkman
, R. Molenaar
, R.M. Hoek
, R.E. Mebius
, L. Meyaard

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	2979-2988
Number of pages	10
Journal	Oncogene
Volume	31
Issue number	24
DOIs	https://doi.org/10.1038/onc.2011.477
Publication status	Published - 2012

Access to Document

10.1038/onc.2011.477

http://www.nature.com/onc/journal/v31/n24/full/onc2011477a.html

Cite this

@article{640342c50b2344179d603e50c67418bb,

title = "CD200-CD200R signaling suppresses anti-tumor responses independently of CD200 expression on the tumor.",

author = "T.P. Rygiel and G. Karnam and G. Goverse and \{van der Marel\}, A.P. and M.J. Greuter and \{van Schaarenburg\}, R.A. and W.F. Visser and A.B. Brenkman and R. Molenaar and R.M. Hoek and R.E. Mebius and L. Meyaard",

year = "2012",

doi = "10.1038/onc.2011.477",

language = "English",

volume = "31",

pages = "2979--2988",

journal = "Oncogene",

issn = "0950-9232",

publisher = "Springer Nature",

number = "24",

}

TY - JOUR

T1 - CD200-CD200R signaling suppresses anti-tumor responses independently of CD200 expression on the tumor.

AU - Rygiel, T.P.

AU - Karnam, G.

AU - Goverse, G.

AU - van der Marel, A.P.

AU - Greuter, M.J.

AU - van Schaarenburg, R.A.

AU - Visser, W.F.

AU - Brenkman, A.B.

AU - Molenaar, R.

AU - Hoek, R.M.

AU - Mebius, R.E.

AU - Meyaard, L.

PY - 2012

Y1 - 2012

U2 - 10.1038/onc.2011.477

DO - 10.1038/onc.2011.477

M3 - Article

C2 - 22020332

SN - 0950-9232

VL - 31

SP - 2979

EP - 2988

JO - Oncogene

JF - Oncogene

IS - 24

ER -